Porto Hospital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Porto hospital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Porto Hospital Today - Breaking & Trending Today

Mineralocorticoid receptor antagonist use does not affect empagliflozin benefit in HFpEF

The benefit of the SGLT2 inhibitor empagliflozin in patients with HF with preserved ejection fraction did not differ between those who did or did not receive mineralocorticoid receptor antagonists, researchers reported.In a prespecified secondary analysis of the EMPEROR-Preserved trial of patients with HFpEF, researchers found that while the effect of empagliflozin (Jardiance, Boehringer ....

Pedro Ferreira , Boehringer Ingelheim Eli Lilly , Centre For Clinical , Journal Of The American College Cardiology , University Of Lorraine , University Of Glasgow , Eli Lilly , Porto Hospital , Plurithematic Investigation , American College ,